Aquestive Therapeutics, Inc. (AQST) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Aquestive Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -9.40x | -7.00x | -15.72x | -0.81x | -2.10x | -3.23x |
| P/B Ratio | -23.41x | -5.13x | -1.16x | -0.37x | -1.80x | -3.71x |
| P/S Ratio | 17.69x | 5.36x | 2.45x | 0.92x | 2.91x | 3.93x |
| Profitability | ||||||
| Gross Margin | 61.5% | 69.0% | 58.8% | 59.3% | 70.5% | 71.7% |
| Operating Margin | -156.4% | -53.5% | -29.9% | -88.2% | -68.2% | -93.6% |
| Net Margin | -188.1% | -76.7% | -15.6% | -114.1% | -138.8% | -121.7% |
| EBITDA Margin | -155.1% | -46.2% | 2.3% | -83.0% | -88.8% | -85.4% |
| Liquidity | ||||||
| Current Ratio | 3.14x | 4.68x | 2.24x | 1.01x | 2.15x | 2.11x |
| Quick Ratio | 3.01x | 4.36x | 1.87x | 0.86x | 1.97x | 2.00x |
| Leverage | ||||||
| Debt/Equity | -3.90x | -0.63x | -0.31x | -0.48x | -0.69x | -0.83x |
YoY = year-over-year change. Source: FMP..